Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Patent Issued

4 Jul 2018 07:00

RNS Number : 5006T
AorTech International PLC
04 July 2018
 

 4 July 2018 

AorTech International plc 

("AorTech" or the "Company") 

  

New Patent Issued

 

AorTech is pleased to announce that the Brazilian Patent Office has recently granted Patent Number PI 0711694-2 entitled Biostable Gels. The invention relates to biostable gels, the processes for their preparation and their use in the manufacture and repair of biomaterials and medical devices or implants, in particular soft tissue implants such as breast implants.

 

Bill Brown, Chairman of AorTech said: "The issue of this patent further expands AorTech's patent portfolio, particularly in the area of breast implants. Brazil is one of the largest markets for breast enhancement outside of the USA and is therefore an important patent territory. The portfolio of IP relating to Breast Implants is not currently licensed by AorTech."

  

For further information contact: 

  

AorTech International plc Tel: +44 (0)7730 718296  

Bill Brown, Chairman  

  

Stockdale Securities Limited Tel: +44 (0)20 7601 6100  

Tom Griffiths/David Coaten  

  

About AorTech: 

  

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA and Japanese Ministry of Health approvals. 

  

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

 

In addition to the licensing of biostable polymers, AorTech is now developing medical devices utilizing the key properties of its world class polymers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLLFERDVIVIIT
Date   Source Headline
28th Sep 20067:03 amRNSAGM Statement
19th Sep 20064:47 pmRNSHolding(s) in Company
15th Sep 20065:09 pmRNSDirector/PDMR Shareholding
13th Sep 20061:32 pmRNSHolding(s) in Company
13th Sep 20061:31 pmRNSHolding(s) in Company
6th Sep 200612:13 pmRNSAnnual Report and Accounts
5th Sep 20067:03 amRNSDirector/PDMR Shareholding
5th Sep 20067:02 amRNSHolding(s) in Company
31st Aug 20067:01 amRNSFinal Results
15th Aug 20067:00 amRNSMedical Advisory Board
7th Aug 20067:02 amRNSFirst human use of ElastEon
1st Aug 20062:20 pmRNSHolding(s) in Company
19th Jul 20067:01 amRNSHolding(s) in Company
30th Jun 200612:20 pmRNSDirector/PDMR Shareholding
23rd Jun 200611:01 amRNSHolding(s) in Company
28th Apr 20063:38 pmRNSConference Presentation
13th Apr 200611:36 amRNSChange of Adviser
6th Apr 20064:06 pmRNSNotification of Interests
20th Mar 20067:01 amRNSSupply and License Agreement
24th Jan 20068:54 amRNSAward of Govt Grant Funding
9th Dec 20057:01 amRNSInterim Results
7th Dec 20057:01 amRNSUpdate of Postal Poll
25th Nov 20057:00 amRNSFDA Approval
17th Nov 20057:01 amRNSAGM Update
15th Nov 20052:25 pmRNSDirectorate Change
27th Oct 20051:06 pmRNSAGM Statement
23rd Sep 20057:01 amRNSFinal Results
1st Aug 20057:01 amRNSSpinal Disc Licence
13th May 20057:00 amRNSBoard Changes
29th Apr 20057:00 amRNSBreast Implants Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.